The Virus filtration market has shown substantial growth over the past few years owing to wide applications in biotherapeutic production, blood and blood products, water purification, and medical devices sterilization. Virus filtration allows the removal of viruses from liquid samples either fluids like serum, plasma, and other biological fluids utilized in vaccine production.
The global Virus Filtration Market is estimated to be valued at US$ 5.86 Mn in 2024 and is expected to exhibit a CAGR of 3.1% over the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the major trends fueling the growth of the virus filtration market is up-scaling pharmaceutical production activities. The rising demand for biotherapeutics worldwide has prompted pharmaceutical companies to increase biologics production capacity substantially. Growing outsourcing of biotherapeutic manufacturing to contract manufacturing organizations (CMOs) has also augmented the requirement for virus filtration units in these facilities. Virus filtration plays a crucial role in detecting and eliminating viral contamination during upstream and downstream processing. Therefore, expansion of biologic drug manufacturing capacities to meet the increasing demand automatically drives the need for virus filtration products.
Strength: Virus filtration helps ensure product safety and prevent costly production losses. The process efficiently inactivates viruses from biological products without compromising quality.
Weakness: Virus filtration systems require significant capital investments and operating costs. Additional regulatory compliance also increases expenses for manufacturers.
Opportunity: Rising recombinant therapeutic antibody production is expanding demand for virus removal technologies during downstream processing. Growing biologics market in Asia Pacific and other emerging regions present new opportunities.
Threats: Stringent regulatory oversight and validation requirements pose challenges. Technology advancements by competitors increase intensity of price-based competition in the industry.
Global Virus Filtration Market Size is expected to witness high growth. The global Virus Filtration Market is estimated to be valued at US$ 5.86 Mn in 2024 and is expected to exhibit a CAGR of 3.1% over the forecast period 2024-2031.
Regional analysis comprises the Asia Pacific region is poised to be the fastest growing market for virus filtration during the forecast period. Increasing outsourcing of biologic drug substance manufacturing to Asian contract manufacturing organizations drives regional growth.
Key players operating in the virus filtration market are Astellas Pharma, Genzyme Corporation, Accord Healthcare Lt. Virus filtration finds widespread application during production of biotherapeutics and vaccines. The process provides a physical barrier against viruses and reliably ensures final drug product safety.
Leading market players are focusing on capacity expansions and new product launches catering to high-growth therapeutic areas. Rising biologics drug pipelines and subsequent commercialization efforts are boosting demand. Industry participants face challenges of equipment and technology upgrades to keep up with evolving regulatory standards.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it